CASEY WATSON: Open Payments
NPI 1164890281 · CHARLOTTE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$875 in 16 payments from 12 companies in 2025. Trend: 2023 $491 · 2024 $620 · 2025 $875
Food & beverage: $875
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 2 | $147 |
| TMS NeuroHealth Centers Inc. | 1 | $139 |
| ABBVIE INC. | 2 | $138 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $108 |
| Axsome Therapeutics, Inc. | 1 | $107 |
| Neurocrine BioSciences, Inc. | 1 | $103 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $48 |
| LivaNova USA, Inc. | 1 | $28 |
| Otsuka America Pharmaceutical, Inc. | 1 | $15 |
| E.R. Squibb & Sons, L.L.C. | 1 | $14 |
Products named: TMS NeuroHealth Centers Inc., VRAYLAR, LYBALVI, CAPLYTA, Auvelity, INGREZZA, TRINTELLIX, VNS THERAPY SYMMETRY MODEL 8103 GENERATOR.
Industry payments across NC — which companies pay providers there.
